Detalhe da pesquisa
1.
Evaluating approaches for constructing polygenic risk scores for prostate cancer in men of African and European ancestry.
Am J Hum Genet
; 110(7): 1200-1206, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311464
2.
Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men.
Hum Mol Genet
; 32(3): 489-495, 2023 01 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36018819
3.
Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
Br J Cancer
; 126(10): 1366-1373, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923574
4.
Correction: Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Br J Cancer
; 120(8): 867, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30837682
5.
Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.
Br J Cancer
; 119(1): 96-104, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29915322
6.
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
Br J Cancer
; 118(2): 266-276, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301143
7.
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
Br J Cancer
; 118(6): e9, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438362
8.
Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.
Br J Cancer
; 118(6): e17, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29509747
9.
Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
Hum Mol Genet
; 24(19): 5589-602, 2015 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025378
10.
LocusExplorer: a user-friendly tool for integrated visualization of human genetic association data and biological annotations.
Bioinformatics
; 32(6): 949-51, 2016 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589274
11.
Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
PLoS Genet
; 10(2): e1004129, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24550738
12.
Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.
Br J Cancer
; 114(8): 945-52, 2016 04 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26964030
13.
Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Hum Genet
; 135(8): 923-38, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27262462
14.
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate Cancer.
Oncologist
; 21(6): 716-22, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27151655
15.
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Hum Mol Genet
; 22(12): 2520-8, 2013 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23535824
16.
Identification of Genes with Rare Loss of Function Variants Associated with Aggressive Prostate Cancer and Survival.
Eur Urol Oncol
; 7(2): 248-257, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458890
17.
Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
BJU Int
; 112(5): 666-73, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23320731
18.
Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study.
Eur Urol
; 83(3): 257-266, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36528478
19.
CanRisk-Prostate: A Comprehensive, Externally Validated Risk Model for the Prediction of Future Prostate Cancer.
J Clin Oncol
; 41(5): 1092-1104, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493335
20.
Serum testosterone and prostate cancer in men with germline BRCA1/2 pathogenic variants.
BJUI Compass
; 4(3): 361-373, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37025481